Aplastic Anemia Treatment

Treatment of aplastic anemia is complex and requires individualized regimens based on disease severity. Common approaches include immunosuppressive therapy, hematopoietic stem cell transplantation, and supportive therapy, aiming to restore bone marrow hematopoietic function and improve patient survival quality. Rational treatment can effectively control the disease and reduce complication risks.

Global Prevalence

Europe and America

In Europe and America, the incidence of aplastic anemia is relatively stable, about 2 to 6 cases per million population annually. With advanced medical conditions, hematopoietic stem cell transplantation and other advanced treatments are widely applied, improving patient survival rates and quality of life.

Southeast Asia

The incidence of aplastic anemia is relatively higher in Southeast Asia, with case numbers increasing annually due to environmental and genetic factors. Limited medical resources in some countries lead to delayed diagnosis and treatment, resulting in poor prognosis, highlighting the urgent need to improve diagnostic and treatment capabilities and healthcare coverage.

Immune Reconstruction Cell Therapy

Immune reconstruction cell therapy restores patients’ immune system function, promotes the regeneration and repair of bone marrow hematopoietic cells, effectively reduces immune-mediated bone marrow damage, improves hematopoietic function, enhances treatment tolerance, and improves survival quality, representing a major breakthrough in aplastic anemia treatment.

1. Promotes immune function recovery

This therapy rapidly enhances patient immunity, reduces infection risks, and helps the body better cope with disease.

2. Improves hematopoietic function

Through immune regulation, it restores the bone marrow environment, enhances hematopoietic stem cell activity, and promotes blood cell generation.

3. Reduces side effects

Compared with traditional methods, immune reconstruction cell therapy has fewer side effects and improves patient treatment compliance.

In actual treatment, traditional regimens often face problems of immune dysfunction, increased infection risks, and slow recovery. To help patients better tolerate treatment, improve endurance, and enhance survival quality, phased immune reconstruction programs must be scientifically designed for different cycles.

● Short-term plan: Rapidly enhance immunity through immune cell reinfusion to strengthen therapeutic effects.

● Mid-term plan: Reduce side effects of conventional treatments, promote recovery, and ensure completion of standardized regimens.

● Long-term plan: Comprehensive enhancement of immunity through immune cell reconstruction, gut immunity restoration, elemental immunity rebuilding, and immune nutrition support, thereby improving quality of life and prolonging survival.

Traditional Treatment Methods

1. Immunosuppressive therapy

Suppresses abnormal immune responses with drugs, alleviates bone marrow damage, and promotes blood cell recovery. It is the fundamental method for treating aplastic anemia.

2. Hematopoietic stem cell transplantation

Suitable for young or severely ill patients, transplantation of healthy stem cells restores bone marrow hematopoietic function and has a high cure rate.

3. Supportive therapy

Includes transfusions, anti-infection treatment, and nutritional support, relieving symptoms and ensuring treatment safety.

4. Hormone therapy</p